The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes

Author： Holstein Judith Dina Kovacs Peter Patzer Olaf Stumvoll Michael Holstein Andreas

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.1, 2012-01, pp. : 5-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients

By Klen Jasna Dolžan Vita Janež Andrej

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert Hagan Michael A.

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)

By Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 935-954

Adis International

Access to resources Recommend Favorite

Exenatide: a guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy

By Bachmann W.

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 679-686

Adis International

Access to resources Recommend Favorite